1. Cellular and molecular portrait of eleven human glioblastoma cell lines under photon and carbon ion irradiation. Issue 1 (28th April 2015) Authors: Ferrandon, S.; Magné, N.; Battiston-Montagne, P.; Hau-Desbat, N.-H.; Diaz, O.; Beuve, M.; Constanzo, J.; Chargari, C.; Poncet, D.; Chautard, E.; Ardail, D.; Alphonse, G.; Rodriguez-Lafrasse, C. Journal: Cancer letters Issue: Volume 360:Issue 1(2015) Page Start: 10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial – PROFIT. (August 2022) Authors: Zhou, K.; Renouf, M.; Perrocheau, G.; Magné, N.; Latorzeff, I.; Pommier, P.; Créhange, G.; Paumier, A.; Bera, G.; Martin, J.; Catton, C.; Bellanger, M.; Supiot, S. Journal: Radiotherapy and oncology Issue: Volume 173(2022) Page Start: 306 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. EP-2289: ABT-199 and cetuximab in combination with photon radiation in head and neck cancer stem cells. (April 2018) Authors: Espenel, S.; Guy, J.B.; Wozny, A.S.; Vallard, A.; Louati, S.; Lauret, A.; Simonet, S.; Ardail, D.; Alphonse, G.; Rancoule, C.; Rodriguez-Lafrasse, C.; Magné, N. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S1263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Harnessing drug/radiation interaction through daily routine practice: Leverage medical and methodological point of view (MORSE 02-17 study). Issue 3 (December 2018) Authors: Vallard, A.; Rancoule, C.; Espenel, S.; Garcia, M.-A.; Langrand-Escure, J.; He, M.Y.; Ben Mrad, M.; El Meddeb Hamrouni, A.; Ouni, S.; Trone, J.-C.; Rehailia-Blanchard, A.; Guillaume, E.; Vial, N.; Riocreux, C.; Guy, J.-B.; Magné, N. Journal: Radiotherapy and oncology Issue: Volume 129:Issue 3(2018) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term Results of a Survey of Prolonged Adjuvant Treatment with Temozolomide in Patients with Glioblastoma (SV3 Study). Issue 8 (August 2015) Authors: Rivoirard, R.; Falk, A.T.; Chargari, C.; Guy, J.-B.; Mery, B.; Nuti, C.; Peoc'h, M.; Forest, F.; Garin, C.; Adjabi, A.; Hoarau, D.; Kawaye, S.; Almokhles, H.; Fournel, P.; Magné, N. Journal: Clinical oncology Issue: Volume 27:Issue 8(2015) Page Start: 486 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. MO-0058 Cost-effectiveness of hypofractionated radiotherapy in intermediate-risk prostate cancer. (May 2022) Authors: Renouf, M.; Zhou, K.; Perrocheau, G.; Magné, N.; De Brisson de la Roche, G.; Latorzeff, I.; Pommier, P.; Créhange, G.; Paumier, A.; Bera, G.; Catton, C.; Bellanger, M.; Supiot, S. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC-0333 Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial. (August 2021) Authors: Laprie, A.; Noel, G.; Chaltiel, L.; Truc, G.; Sunyach, M.; Charissoux, M.; Magné, N.; Auberdiac, P.; Ken, S.; Roux, F.; Vieillevigne, L.; Tensaouti, F.; Catalaa, I.; Boetto, S.; Uro-Coste, E.; Supiot, S.; Bernier, V.; Filleron, T.; Mounier, M.; Poublanc, M. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC-0607 Radiotherapy guided by functional imaging for macroscopic local recurrence following prostatectomy. (May 2022) Authors: Benziane, N.; Sargos, P.; Zilli, T.; Giraud, A.; Ingrosso, G.; Di Staso, M.; Trippa, F.; Meyer, E.; Francolini, G.; Schick, U.; Cosset, J.M.; Martin, E.; Ferrari, V.; Achard, V.; Giraud, N.; Pasquier, C.; Magné, N.; Pasquier, D.; Supiot, S.; Latorzeff, I. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S532 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC-0615 Predicting urinary toxicity via 2D and 3D dose map analyses in prostate cancer radiotherapy. (April 2019) Authors: Mylona, E.; Cicchetti, A.; Rancati, T.; Palorini, F.; Supiot, S.; Magné, N.; Crehange, G.; Acosta, O.; De Crevoisier, R. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S326 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC-0626 Is pre-radiotherapy metabolic heterogeneity of Glioblastoma predictive of progression free survival?. (May 2022) Authors: Tensaouti, F.; Desmoulin, F.; Gilhodes, J.; Ken, S.; Lotterie, J.; Noël, G.; Truc, G.; Sunyach, M.; Charissoux, M.C.; Magné, N.; Lubrano, V.; Péran, P.; Moyal, E.C.; Laprie, A. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S555 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗